HOME >> MEDICINE >> NEWS
Delirium in non-ventilated patients predictor of longer hospital stay

A study published today in the journal Critical Care reveals for the first time that nearly half of non-ventilated patients in intensive care units (ICU) experience delirium, which is also an independent predictor of longer hospital stay. It was previously though that this was only an issue for mechanically-ventilated ICU patients. Researchers recommend regular monitoring of all ICU patients to prevent and treat delirium, which is both harmful to patients and costly to hospitals.

Delirium occurs in 60 to 80% of mechanically ventilated patients and is independently associated with more deaths, longer stays in hospital and higher costs: every day spent in delirium is associated with a 10% higher risk of death and decreased long-term cognitive function.

E.Wesley Ely, from Vanderbilt University Medical Centre, USA, and colleagues followed a total of 261 individuals who were patients in the medical centre's intensive care unit for longer than 24 hours and did not require invasive mechanical ventilation. The patients were followed from their admission to either death or discharge from the hospital. Delirium, or a state of changing mental status, inattention and disorganised thinking, was monitored by the nursing staff and assessed using the Confusion Assessment Method for the Intensive Care Unit every 12 hours.

The results show that 48% of patients experienced delirium. This group of patients had a higher mortality rate: 19% of them died, compared to just 6% of patients who hadn't experienced delirium. Patients who experienced delirium at least once also had a 29% greater risk of remaining in the ICU and a 41% greater risk of remaining in the hospital. Overall, delirium was associated with a one day longer stay in the ICU and two days longer in the hospital.

"Considering the rising overall resource use and economic burden of caring for critically ill patients, our finding that ICU delirium is an independent predictor of longer stay in the
'"/>

Contact: Juliette Savin
juliette@biomedcentral.com
44-0-207-631-9931
BioMed Central
31-May-2005


Page: 1 2

Related medicine news :

1. Delirium associated with premature death
2. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
3. Comparison of obstetric outcomes between on-call and patients own obstetricians
4. Researchers find vitamin B1 deficiency key to vascular problems for diabetic patients
5. Stem cell transplantation procedure results in long-term survival for amyloidosis patients
6. Happier hospitals means healthier patients
7. Many heart attack patients still not getting emergency clot-busting treatment
8. HealthGrades study: Bariatric surgery patients have fewer complications at high-volume hospitals
9. 6 out of 10 doctors arent frustrated that patients cant lower cholesterol
10. Program announced to improve care in developing areas for patients with blood disorders
11. When minority patients have insurance and a medical home, their health care improves

Post Your Comments:
(Date:5/21/2013)... (PRWEB) May 21, 2013 DISCcert has ... showing how to use 17 DISC applications at the ... a natural progression. , The July 25 & 26th ... top 17 ways of applying DISC. The time-tested, proven ... graduates. The user-friendly DISC training materials ; ...
(Date:5/21/2013)... 21, 2013) Prostaglandin analogues (PGAs), drugs which lower ... for people with glaucoma, but their use is not ... vision, dryness, changes in eye color and other side ... drugs also cause upper and lower eyelid drooping and ... are described in PLOS ONE . , Researchers ...
(Date:5/21/2013)... Mecklenburg EMS Agency (Medic) and ... free Community Wellness Fair to educate the public on health ... held on Wednesday, May 22, 2013 from 4:00 pm until ... Old Mallard Creek Road, Charlotte, NC 29262). , ... the Mecklenburg County Department of Social Services are ...
(Date:5/21/2013)... 2013, Paris, France: One-year results from SOURCE XT ... (TAVI) registries to-date reported today at EuroPCR 2013 ... high rates of device success for all access approaches, ... Post-Approval Study followed up 2688 consecutively enrolled patients (mean ... heart valve at 93 centres in 17 countries between ...
(Date:5/21/2013)... Angeles, CA (PRWEB) May 21, 2013 According ... “Time to Rethink the Use of Botox,” Botox ... world since their approval in 2002 (Go to goo.gl/8iYbD). Although ... become quite popular with men. The injection makes facial wrinkles ... single Botox injection last for about three months. This means ...
Breaking Medicine News(10 mins):Health News:DISCcert Offers 17 Applications in Coming DISC Certification 2Health News:DISCcert Offers 17 Applications in Coming DISC Certification 3Health News:DISCcert Offers 17 Applications in Coming DISC Certification 4Health News:Glaucoma drug can cause droopy eyelids 2Health News:Mecklenburg EMS Agency Teams Up with the YMCA of Greater Charlotte and Others to Educate the Public on Health Related Initiatives 2Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2
(Date:5/21/2013)... , May 21, 2013  Decision Resources, ... advisory firms for pharmaceutical and healthcare issues, ... agent on key efficacy endpoints, including overall ... the most influence over surveyed U.S. and ... (HR-) positive, HER2-negative breast cancer. The two ...
(Date:5/21/2013)... NORTH BRUNSWICK, N.J. , May 21, 2013 /PRNewswire/ ... artificial tissue constructs and microfluidic cell-based assay platforms, today ... , PhD, DABT to the Company,s Board of ... of Preclinical Development of the Schering-Plough Research Institute ("SPRI"), ... prior to its acquisition by Merck & Co. in ...
(Date:5/21/2013)... , May 21, 2013 ... report is available in its catalogue: ... and Technologies for Optical Coherence Tomography (OCT) ... STUDY OBJECTIVES   ... study is to offer synopsis of the ...
Breaking Medicine Technology:Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2Global Markets and Technologies for Optical Coherence Tomography (OCT) 2Global Markets and Technologies for Optical Coherence Tomography (OCT) 3Global Markets and Technologies for Optical Coherence Tomography (OCT) 4Global Markets and Technologies for Optical Coherence Tomography (OCT) 5Global Markets and Technologies for Optical Coherence Tomography (OCT) 6Global Markets and Technologies for Optical Coherence Tomography (OCT) 7Global Markets and Technologies for Optical Coherence Tomography (OCT) 8Global Markets and Technologies for Optical Coherence Tomography (OCT) 9Global Markets and Technologies for Optical Coherence Tomography (OCT) 10Global Markets and Technologies for Optical Coherence Tomography (OCT) 11Global Markets and Technologies for Optical Coherence Tomography (OCT) 12Global Markets and Technologies for Optical Coherence Tomography (OCT) 13Global Markets and Technologies for Optical Coherence Tomography (OCT) 14Global Markets and Technologies for Optical Coherence Tomography (OCT) 15Global Markets and Technologies for Optical Coherence Tomography (OCT) 16Global Markets and Technologies for Optical Coherence Tomography (OCT) 17Global Markets and Technologies for Optical Coherence Tomography (OCT) 18Global Markets and Technologies for Optical Coherence Tomography (OCT) 19
Cached News: